Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Kali Inc (EM) KALY

Healthcare Apparel Manufacturing Biotechnology Cannabis
Kali, Inc., doing business as Kali-Extracts, Inc., engages in the research and development of cannabis treatments for various illnesses, diseases, and chronic pain as a symptom of various diagnoses. It provides pharmaceuticals, cannabis extracts, and health and wellness products. The company was formerly known as VLOV Inc. and changed its name to Kali, Inc. in February 2016. Kali, Inc. is based... see more

Recent & Breaking News (EXPM:KALY)

Kalytera Reports First Quarter 2017 Financial Results

GlobeNewswire May 31, 2017

Kalytera Announces Changes to its Board of Directors

GlobeNewswire May 26, 2017

Kali Inc. Considers Cannabis Sector Opportunity Separate From Kalytera

ACCESS Newswire February 23, 2017

Kali Inc Anticipates Puerto Rico Marina Management Project to Triple to $30 Million

PR Newswire February 23, 2017

IIROC Trading Resumption - KALY

Canada NewsWire January 18, 2017

IIROC Trade Resumption - Kalytera Therapeutics, Inc.

Newsfile January 18, 2017

Kalytera Therapeutics Announces Preliminary Results of a Phase 2a Clinical Study in the Prevention of Graft versus Host Disease

ACCESS Newswire January 18, 2017

IIROC Trading Halt - KALY

Canada NewsWire January 18, 2017

IIROC Trade Halt - Kalytera Therapeutics, Inc.

Newsfile January 18, 2017

IIROC Trading Resumption - KALY

Canada NewsWire January 13, 2017

IIROC Trade Resumption - Kalytera Therapeutics, Inc.

Newsfile January 13, 2017

Kalytera Therapeutics Enters into Binding Letter of Intent to Acquire Talent Biotechs and its Phase 2 Clinical-Stage Graft versus Host Disease Program

MarketWire Canada January 13, 2017

IIROC Trading Halt - KALY

Canada NewsWire January 13, 2017

IIROC Trade Halt - Kalytera Therapeutics, Inc.

Newsfile January 13, 2017

Kalytera Therapeutics, Inc. Grants Stock Options

MarketWire Canada January 11, 2017

IIROC Trade Resumption - Kalytera Therapeutics, Inc.

Newsfile January 11, 2017

IIROC Trading Resumption - CBM.H; KALY

Canada NewsWire January 10, 2017

IIROC Trade Resumption - Kalytera Therapeutics, Inc.

Newsfile January 10, 2017

Kali, Inc. to Expand Caribbean Operations on Foundation of First $10 Million Caribbean Marina Project

ACCESS Newswire January 5, 2017

Kalytera Therapeutics, Inc. (formerly Santa Maria Petroleum Inc.) Closes Reverse Takeover Transaction

MarketWire Canada December 30, 2016

Podcasts